These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23144808)

  • 41. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
    Irwin C; Roberts W; Naseem KM
    Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet activity is negatively modulated by tumor necrosis factor alpha through reductions of cytosolic calcium levels and integrin alphaIIbbeta3 phosphorylation.
    Bonfitto PHL; Naime ACA; Lopes-Pires ME; Goulart G; Mendes-Silverio CB; Bueno PI; Castilho RF; Antunes E; Marcondes S
    Thromb Res; 2018 Dec; 172():44-50. PubMed ID: 30359790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct sGC activation bypasses NO scavenging reactions of intravascular free oxy-hemoglobin and limits vasoconstriction.
    Raat NJ; Tabima DM; Specht PA; Tejero J; Champion HC; Kim-Shapiro DB; Baust J; Mik EG; Hildesheim M; Stasch JP; Becker EM; Truebel H; Gladwin MT
    Antioxid Redox Signal; 2013 Dec; 19(18):2232-43. PubMed ID: 23697678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood.
    Reiss C; Mindukshev I; Bischoff V; Subramanian H; Kehrer L; Friebe A; Stasch JP; Gambaryan S; Walter U
    Br J Pharmacol; 2015 Nov; 172(21):5199-210. PubMed ID: 26282717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra.
    Toque HA; Antunes E; Teixeira CE; De Nucci G
    Urology; 2008 Sep; 72(3):711-5. PubMed ID: 18359064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Responsiveness of rat aorta and pulmonary artery to cGMP generators in the presence of thiol or heme oxidant.
    Tawa M; Yamashita Y; Masuoka T; Nakano K; Yoshida J; Nishio M; Ishibashi T
    J Pharmacol Sci; 2019 May; 140(1):43-47. PubMed ID: 31036520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy.
    Irvine JC; Ganthavee V; Love JE; Alexander AE; Horowitz JD; Stasch JP; Kemp-Harper BK; Ritchie RH
    PLoS One; 2012; 7(11):e44481. PubMed ID: 23144773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
    Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
    J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice.
    Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E
    J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
    Xie G; Wang X; Wang L; Wang L; Atkinson RD; Kanel GC; Gaarde WA; Deleve LD
    Gastroenterology; 2012 Apr; 142(4):918-927.e6. PubMed ID: 22178212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
    Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
    J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
    Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.
    Marcondes S; Cardoso MH; Morganti RP; Thomazzi SM; Lilla S; Murad F; De Nucci G; Antunes E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3434-9. PubMed ID: 16492779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.
    Roy B; Mo E; Vernon J; Garthwaite J
    Br J Pharmacol; 2008 Apr; 153(7):1495-504. PubMed ID: 18204474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
    Dismuke WM; Sharif NA; Ellis DZ
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3353-9. PubMed ID: 19234350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
    Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
    Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor.
    Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE
    Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosine 135 of the β
    Rühle A; Elgert C; Hahn MG; Sandner P; Behrends S
    Eur J Pharmacol; 2020 Aug; 881():173203. PubMed ID: 32446711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.